ATLANTA--(BUSINESS WIRE)--Dec. 29, 2005--Altea Therapeutics has been named a winner of a Georgia Biomedical Partnership (GBP) Deal of the Year award for a venture capital financing that raised almost $33 million, the largest venture capital deal in Georgia for 2005. Altea Therapeutics, an emerging pharmaceutical company developing transdermal patches for the delivery of proteins and water-soluble drugs, raised $32.8 million in a third round of venture capital financing led by Aperture Venture Partners. The investor syndicate also included previous investors Domain, Venrock and vSpring Capital together with KBC, Quilvest, CX Ventures and Rockport Ventures.
